Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.11
0.15 (0.60%)
At close: Aug 15, 2025, 12:52 PM

Assembly Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.52M 7.16M n/a 6.25M
Cost of Revenue
n/a 48.9M 498K 466K
Gross Profit
28.39M -41.74M -498K 5.79M
Operating Income
-45.42M -64.65M -94.11M -132.69M
Interest Income
5.57M 3.45M 1.02M 302K
Pretax Income
-39.85M -61.2M -93.09M -132.39M
Net Income
-40.18M -61.23M -92.07M -129.85M
Selling & General & Admin
18.01M 22.91M 24.13M 28.78M
Research & Development
55.93M 48.9M 69.98M 68.52M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
73.94M 71.81M 94.11M 97.3M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
73.94M 71.81M 94.11M 97.3M
Income Tax Expense
330K 33K -1.02M -2.53M
Shares Outstanding (Basic)
6M 4.58M 4.03M 46.54M
Shares Outstanding (Diluted)
6M 4.58M 4.03M 46.85M
EPS (Basic)
-6.69 -13.38 -22.82 -2.79
EPS (Diluted)
-6.69 -13.38 -22.82 -2.77
EBITDA
-45.42M -64.2M -92.59M -91.93M
EBIT
-45.42M -64.65M -93.09M -91.05M
Depreciation & Amortization
129K 450K 498K 466K